Dementia cases to triple by 2050

The incidence of Dementia is set to triple in the next 30 years owing to population growth and longer life expectancy. The study examined 4 major risk factors: obesity, high blood sugar, smoking and level of education. Read more below.. We’ve added an education update covering Dementia & Alzheimers from be sure to …

Dementia cases to triple by 2050 Read More »

Roactemra supply pressure to continue as EMA approves COVID-19 indication

Ongoing Roactemra supply difficulties are set to continue as the European Medicines Agency approves its use for adults with severe COVID-19  who are in receipt of systemic treatment with corticosteroids and requiring supplemental oxygen or mechanical ventilation. Read more below.. RoActemra (tocilizumab) approved by EMA for use in severe COVID-19    

New Oral Anti-Covid Treatments – get full details here

Oral anti-Covid treatments have been developed and licenced for use – Lagevrio and Paxlovid. Dr JJ Keating and Dr Tim O’Sullivan from the UCC School of Pharmacy explain everything in this article. SPC link for Lagevrio:      

Risk of Long-Covid halved with double vaccination -The Lancet

Data published in The Lancet has found that the risk of having COVID symptoms for 28 days or more after post-vaccination infection were approximately halved. Read more below..